Global prevalence and molecular characterization of extended-spectrum beta-lactamase producing-Escherichia coli in dogs and cats - A scoping review and meta-analysis
dc.contributor.author | Salgado Caxito, Marilia | |
dc.contributor.author | Benavides, Julio A. | |
dc.contributor.author | Adell, Aiko D. | |
dc.contributor.author | Paes, Antonio Carlos | |
dc.contributor.author | Moreno Switt, Andrea, I | |
dc.date.accessioned | 2024-01-10T14:23:31Z | |
dc.date.available | 2024-01-10T14:23:31Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Antimicrobial resistance (AMR) represents a major threat to human and animal health. Part of the AMR dimension is the circulation of extended-spectrum ?-lactamases producing-Escherichia coli (ESBL-E. coli), which is now commonly reported among companion animals. However, the global perspective of the prevalence and population structure of ESBL-E. coli circulating in dogs and cats has not been estimated limiting our understanding of their role in the dissemination of ESBL-E. coli. The aim of this study was to compare the prevalence of ESBL-E. coli between dogs and cats and across countries through meta-analysis. We also performed a scoping review to summarize the current knowledge on ESBL genes and E. coli clones circulating among companion animals. A total of 128 studies published in PubMed, Web of Science, and Scopus up to April 2020 were selected and contained information on prevalence and/or molecular characterization of ESBL genes and ESBL-E. coli clones. Our review shows an increase in the number of publications between 2000 and 2019, concentrated mainly in Europe. Prevalence varied across continents, ranging from 0.63% (Oceania) to 16.56% (Africa) in dogs and from 0% (Oceania) to 16.82% (Asia) in cats. Although there were twice as many studies reporting prevalence on dogs (n = 61) than on cats (n = 32), and only 9 studies focused exclusively on cats, our meta-analysis showed no difference in the global prevalence of ESBL-E. coli between dogs (6.87% [95% CI: 4.46?10.45%]) and cats (5.04% [95% CI: 2.42?10.22%]). A considerable diversity of ESBL genes (n = 60) and sequence types (ST) (n = 171) were recovered from companion animals. ESBL-E. coli encoded by CTX-M-15 (67.5%, 77/114) and SHV-12 (21.9%, 25/114), along with resistant strains of ST38 (22.7%, 15/66) and ST131 (50%, 33/66) were widespread and detected in all continents. While presence of ESBL-E. coli is widespread, the drivers influencing the observed ESBL-E. coli prevalence and the clinical relevance in veterinary medicine and public health along with economic impact of ESBL-E. coli infections among companion animals need to be further investigated. | |
dc.description.funder | Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) | |
dc.description.funder | FONDECYT | |
dc.description.funder | ANID Millennium Science Initiative/Millennium Initiative for Collaborative Research on Bacterial Resistance, MICROB-R | |
dc.fechaingreso.objetodigital | 03-04-2024 | |
dc.format.extent | 15 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1016/j.onehlt.2021.100236 | |
dc.identifier.eissn | 2352-7714 | |
dc.identifier.pubmedid | MEDLINE:33889706 | |
dc.identifier.uri | https://doi.org/10.1016/j.onehlt.2021.100236 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/80106 | |
dc.identifier.wosid | WOS:000644329100007 | |
dc.information.autoruc | Facultad de Agronomía e Ingeniería Forestal; Moreno Switt, Andrea Isabel; S/I; 1147061 | |
dc.language.iso | en | |
dc.nota.acceso | contenido completo | |
dc.publisher | ELSEVIER | |
dc.rights | acceso abierto | |
dc.subject | Antimicrobial resistance | |
dc.subject | Companion animals | |
dc.subject | ESBL | |
dc.subject | Pets | |
dc.subject | Resistance genes | |
dc.subject | Worldwide | |
dc.subject | MEDIATED QUINOLONE RESISTANCE | |
dc.subject | COMPANION ANIMALS | |
dc.subject | RISK-FACTORS | |
dc.subject | CTX-M | |
dc.subject | ANTIMICROBIAL RESISTANCE | |
dc.subject | CEPHALOSPORIN RESISTANCE | |
dc.subject | FECAL COLONIZATION | |
dc.subject | INCFII PLASMIDS | |
dc.subject | 1ST DETECTION | |
dc.subject | HEALTHY DOGS | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Global prevalence and molecular characterization of extended-spectrum beta-lactamase producing-Escherichia coli in dogs and cats - A scoping review and meta-analysis | |
dc.type | artículo de revisión | |
dc.volumen | 12 | |
sipa.codpersvinculados | 1147061 | |
sipa.index | WOS | |
sipa.index | Pubmed | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2024-04-03. Global prevalence and molecular characterization of extended-spectrum beta-lactamase producing-Escherichia coli in dogs and cats - A scoping review and meta-analysis.pdf
- Size:
- 3.01 MB
- Format:
- Adobe Portable Document Format
- Description: